Patel Prital, Woodgett James R
Lunenfeld-Tanenbaum Research Institute, Sinai Health System & University of Toronto, Toronto, ON, Canada.
Lunenfeld-Tanenbaum Research Institute, Sinai Health System & University of Toronto, Toronto, ON, Canada.
Curr Top Dev Biol. 2017;123:277-302. doi: 10.1016/bs.ctdb.2016.11.011. Epub 2016 Dec 28.
Glycogen synthase kinase-3 (GSK-3) is an unusual protein-serine kinase in that it is primarily regulated by inhibition and lies downstream of multiple cell signaling pathways. This raises a variety of questions in terms of its physiological role(s), how signaling specificity is maintained and why so many eggs have been placed into one basket. There are actually two baskets, as there are two isoforms, GSK-3α and β, that are highly related and largely redundant. Their many substrates range from regulators of cellular metabolism to molecules that control growth and differentiation. In this chapter, we review the characteristics of GSK-3, update progress in understanding the kinase, and try to answer some of the questions raised by its unusual properties. Indeed, the kinase may trigger transformation in our thinking of how cellular signals are organized and controlled.
糖原合酶激酶-3(GSK-3)是一种独特的蛋白质丝氨酸激酶,因为它主要通过抑制作用进行调节,且位于多个细胞信号通路的下游。这就引发了一系列关于其生理作用、信号特异性如何维持以及为何将如此多的“鸡蛋”放在一个“篮子”里的问题。实际上有两个“篮子”,因为有两种亚型,即GSK-3α和β,它们高度相关且在很大程度上功能冗余。它们的众多底物涵盖从细胞代谢调节因子到控制生长和分化的分子。在本章中,我们将综述GSK-3的特性,更新对该激酶的理解进展,并尝试回答由其独特性质引发的一些问题。事实上,该激酶可能会促使我们在思考细胞信号如何组织和控制方面发生转变。